biopath holdings shares fell 18 to 174 monday after fridays announcement of a stock and warrant offering on friday its shares rose 9 marking the fourth consecutive day of increases the oncologyfocused biotechnology company didnt list the expected size of the offering biopath intends to use proceeds for working capital and general corporate purposes